PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Why aren’t more older adults getting flu or COVID-19 shots?

Poll suggests need for more communication about vaccines’ power to reduce risk of severe illness in people over 50

2026-02-03
(Press-News.org) This winter’s brutal flu season isn’t over, and COVID-19 cases have risen recently too. But a new poll taken in recent weeks shows that vaccination against both viruses lags among people 50 and over, and the national survey reveals key reasons why.

In all, the University of Michigan National Poll on Healthy Aging shows, 42% of people over 50 haven’t gotten either flu or COVID-19 vaccines in the past six months, though 29% have gotten both and 27% have gotten just the updated flu shot.

The poll also asked about COVID-19 vaccination since it became available in 2021: 49% of people over 50 said it’s been more than a year since their last dose, and 15% said they’ve never received it.

The leading reason people over 50 gave for not getting updated vaccines?

They didn’t think they needed them.

In all, 28% of people over 50 who didn’t get a flu vaccine in the past six months, and 29% of those who didn’t get a COVID-19 vaccine in the past year or ever, gave this as the main reason.

That’s despite clear evidence showing that staying up to date on both vaccines reduces the risk of serious illness and death in older adults, whose immune systems need regular “reminders” with updated vaccines tailored to recent mutations in the viruses.

Coming in second among reasons for not getting vaccinated recently were worries about the vaccines’ side effects (19% for flu and 27% for COVID-19), followed by a belief that the vaccines aren’t effective (18% and 19%, respectively).

Far fewer (10% for flu and 6% for COVID-19, respectively) said they just didn’t think of it. A few (4% and 3%) wanted to wait, and from 1% to 4% cited time, cost, insurance, availability or eligibility concerns.

The findings could help health care providers and public health agencies communicate better with middle-aged and older adults about the health benefits of annual vaccination and address any concerns, misinformation, or barriers.

The poll is based at the U-M Institute for Healthcare Policy and Innovation and supported by Michigan Medicine, U-M's academic medical center.

From late December 2025 to mid-January 2026, the poll team asked 2,964 U.S. adults age 50 and over if they’d gotten a flu vaccine dose in the last six months, and when their most recent COVID-19 vaccination was. Then, the team asked those who hadn’t sought vaccination recently their main reason why.

“The evidence is clear: these viruses can lead to serious illness, hospitalization, and death. That risk increases with age and underlying health conditions, and vaccination reduces that risk,” said Jeffrey Kullgren, M.D., M.P.H., M.S., the poll’s director, an Associate Professor of Internal Medicine at the U-M Medical School and a primary care physician at the VA Ann Arbor Healthcare System.

“These findings suggest that we must do a much better job helping people in their 50s and up understand that they will benefit from getting these updated vaccines each year, that the vaccine side effects are mild and short-lived, and that even if they later get infected and develop symptoms, vaccination means they won’t get as sick,” he added.

Emphasizing individual impacts is important, he noted. Experts and news stories often discuss vaccine effectiveness in percentages based on how well the vaccine reduces the risk of hospitalization or death in a population.

That’s different from what an individual might care most about: whether it will keep them from getting sick at all, or seriously ill, Kullgren said.

Even when a vaccine isn’t a perfect match for the virus strains that are circulating, a recent dose still nudges the immune system to be ready to fight off the virus in general, and can help reduce the severity and duration of symptoms, he notes.

No impact from changed recommendation for COVID-19 shot

Last spring, leaders at the U.S. Food and Drug Administration signaled a change in the agency’s recommendation about which adults should receive the COVID-19 vaccination. This was followed by an official change in the FDA approval and the recommendation from the Centers for Disease Control and Prevention in late summer.

But the poll suggests this change didn’t play a major role in older adults’ decision-making. Less than 1% of respondents who chose not to get vaccinated against COVID-19 in the last year said their main reason was they thought they weren’t eligible.

And in fact, the federal change only affects some of those who were polled: Those who are aged 50 to 64 without any chronic health condition that raises COVID-19 risk.

COVID-19 vaccination is still recommended for most older adults, including two doses a year for everyone over age 65 and anyone with a compromised immune system, and one dose a year for those under 65 who have underlying health conditions that put them at higher risk of severe COVID-19.

Many people ages 50 to 64 have at least one of those qualifying conditions, which include diabetes, asthma, obesity, high blood pressure, current or previous smoking, and physical inactivity.

The CDC didn’t change its recommendation that everyone over the age of 6 months should get an annual flu vaccination. And major medical societies and insurance companies announced that they would continue recommending or covering both vaccines for all children over 6 months and all adults, regardless of health status.

Differences in vaccination uptake

In addition to revealing reasons older adults didn’t get updated vaccines, the new poll data show some key differences in vaccination among different groups of people 50 and over.

The oldest adults (age 75 and over)– those with the highest risk of hospitalization and death from both viruses – had the highest rates of updated vaccination.

In all, 46% of those age 75 and up said they had gotten a COVID-19 vaccine in the last six months, compared with 37% of those age 65 to 74 and 20% of those age 50 to 64.

Flu vaccination was even higher in all age groups, with 76% of those in the oldest age bracket having gotten the latest flu shot, compared with 64% of those age 65 to 74 and 42% of those in their 50s and early 60s.

"This gap between flu and COVID-19 vaccination represents an opportunity to connect the dots for older patients: both of these viruses can put them at risk, both of them mutate rapidly, and both vaccines should be an annual tradition, even if they don’t get them at the same time,” said Kullgren.

He also points to the poll’s positive finding that adults 50 and over who report having at least one chronic health condition were much more likely to have gotten flu and COVID-19 shots recently than those without a chronic condition.

But even among those with chronic health conditions, 39% said they hadn’t had either vaccine in the last six months, though this rate was much lower than the 59% of those without chronic conditions who said so.

The poll also suggests a need for focus on those who have never gotten vaccinated against COVID-19, as they grow older and their risk of severe outcomes rises.

In all, 20% of those age 50 to 64 said they had never gotten a COVID-19 vaccine, along with 12% of those age 65 to 75 and 7% of those age 75 and up.

There’s also an income gap, with 19% of all those with household incomes under $60,000 saying they’ve never had a COVID-19 shot, compared with 12% of those with incomes over $60,000.

Not too late to vaccinate, including second doses of COVID-19 vaccine

Kullgren notes that it’s not too late in the current respiratory virus season for anyone to get a flu or COVID-19 vaccine if they haven’t already done so. It’s also almost time for second doses of the COVID-19 vaccine for those over 65 or with moderately to severely compromised immune systems who got this year’s version soon after it arrived in early September. They are recommended to get another dose starting six months after receiving the first.

So, if someone received their first dose in the first week of September, for instance, they can receive a second dose starting the first week in February. See the detailed adult vaccine schedule and the page about COVID-19 vaccines for immunocompromised people.

About the poll

The poll findings come from a nationally representative survey conducted by NORC at the University of Chicago for IHPI and administered online and via phone from December 29, 2025 to January 13, 2026 among 2,964 U.S. adults ages 50 to 98. The sample was weighted to reflect the national population. 

Read past National Poll on Healthy Aging reports and Michigan findings, and learn about the poll methodology. 

END


ELSE PRESS RELEASES FROM THIS DATE:

From leadership to influencers: New ASU study shows why we choose to follow others

2026-02-03
For a long time, most scientists believed that early human hunter-gatherer societies were mostly equal, with little hierarchy or leadership, and that strong inequalities only emerged later with farming and complex societies.  However, new research out of Arizona State University is challenging this. Archaeological finds, ethnographic studies and now psychological research suggest that inequality in influence — who people listen to, copy, and follow — may have been part of human societies deep into our evolutionary past. “At some point in our past, humans became reliant on culture,” ...

‘Celtic curse’ genetic disease hotspots revealed in UK and Ireland

2026-02-03
People from the Outer Hebrides and north-west Ireland have the highest risk of developing a genetic disease that causes a dangerous build-up of iron in the body, a study suggests. The study marks the first time the genetic risk for haemochromatosis – also known as the ‘Celtic curse’ – has been mapped across the UK and Ireland, despite a high incidence of the condition among Scottish and Irish populations. Targeting genetic screening for the condition to priority areas could help identify at-risk individuals earlier and avoid future health ...

Study reveals two huge hot blobs of rock influence Earth’s magnetic field

2026-02-03
Exploring Earth’s deep interior is a far bigger challenge than exploring the solar system. While we have travelled 25 billion km into space, the deepest we have ever gone below our feet is just over 12 km. Consequently, little is known about the conditions at the base of the mantle and the top of the core – the most significant interface in the Earth’s interior and the region where new research has now uncovered exciting magnetic activity. In a study published in Nature Geoscience, research led by the University of Liverpool ...

RCT demonstrates effectiveness of mylovia, a digital therapy for female sexual dysfunction

2026-02-03
Sexual dysfunction is a reality for many women, but the subject remains taboo. A large percentage of women remain untreated, a problem that is exacerbated by the shortage of treatment options for female sexual dysfunction. A research team from GAIA in Hamburg, in cooperation with the Institute for Sexual, Psycho- and Trauma Therapy in Munich, the University of Lübeck, and the Medical School Hamburg, has now investigated the digital therapy “mylovia” The results of the randomized controlled trial (RCT) were published today in the peer-reviewed journal npj Digital Medicine and show a statistically significant and clinically relevant effect of mylovia. mylovia ...

Wistar scientists demonstrate first-ever single-shot HIV vaccine neutralization success

2026-02-03
PHILADELPHIA — (TUESDAY, FEB. 3, 2026) — Scientists at The Wistar Institute have developed an HIV vaccine candidate that achieves something never before observed in the field: inducing neutralizing antibodies against HIV after a single immunization in nonhuman primates. The innovative approach, published in Nature Immunology, could significantly shorten and simplify HIV vaccination protocols, making them more accessible worldwide. The research, led by Amelia Escolano, Ph.D., assistant professor in Wistar’s Vaccine and Immunotherapy Center and the senior author of the study, ...

Medical AI models need more context to prepare for the clinic

2026-02-03
Medical artificial intelligence is a hugely appealing concept. In theory, models can analyze vast amounts of information, recognize subtle patterns in data, and are never too tired or busy to provide a response. However, although thousands of these models have been and continue to be developed in academia and industry, very few of them have successfully transitioned into real-world clinical settings. Marinka Zitnik, associate professor of biomedical informatics in the Blavatnik Institute at Harvard Medical ...

Psilocybin shows context-dependent effects on social behavior and inflammation in female mice modeling anorexia

2026-02-03
CLAYTON, Victoria, AUSTRALIA, 3 February 2026 -- Researchers led by Dr. Claire Foldi at Monash University have discovered that psilocybin, the psychoactive compound found in magic mushrooms, produces subtle but distinct effects on social behavior and inflammation that depend critically on metabolic and exercise context in female mice. The peer-reviewed study, published in Psychedelics, represents the first systematic investigation of how this compound influences sociability in female mice exposed to activity-based anorexia (ABA), a widely ...

Mental health crisis: Global surveys expose who falls through the cracks and how to catch them

2026-02-03
NEWTON, Massachusetts, USA, 3 February 2026 -- In a comprehensive Genomic Press Interview published today in Genomic Psychiatry, Dr. Ronald C. Kessler, the McNeil Family Professor of Health Care Policy at Harvard Medical School, reflects on a career that fundamentally altered how researchers and policymakers across the globe understand the prevalence, distribution, and treatment of mental disorders. With secondary appointments as Professor of Epidemiology at the Harvard T.H. Chan School of Public Health, Program Director at the University of Michigan Institute for Social Research, and at the Massachusetts General Hospital Center for Precision Psychiatry, Dr. Kessler has built an unparalleled ...

New boron compounds pave the way for easier drug development

2026-02-03
A major step towards simpler drug development has been taken at the University of Gothenburg. In a new study, researchers have developed stable boron-fluorine compounds that make it possible to increase the effect or reduce side effects without breaking down the medicine. Chemical compounds based on the element boron are central tools in modern chemistry and are used, among other things, to build drugs, advanced materials, and molecules for medical diagnostics. Some types of boron compounds are still difficult to produce, especially when the boron atom must be placed very precisely in a complex molecule. This limits the possibilities for ...

Are cats ‘vegan’ meat eaters? Study finds why isotopic fingerprint of cat fur could trick us into thinking that way

2026-02-03
Cats – unlike humans – are true carnivores: they must eat meat to survive because their bodies can’t draw some essential nutrients from plants. By looking at tissues, researchers can get a good understanding of what foods animals ate. Now, researchers at the Department of Microbiology and Ecosystem Science at the University of Vienna measured nitrogen and its stable isotopes 15N and 14N in the fur and whiskers of domestic cats as well as in cat food available in supermarkets. They then compared nitrogen isotope values to those found in the hair of humans ...

LAST 30 PRESS RELEASES:

Oxygen-modified graphene filters boost natural gas purification

A new thermoelectric material to convert waste heat to electricity

Restricting mothers' migration: New evidence on children’s health and education

Why aren’t more older adults getting flu or COVID-19 shots?

From leadership to influencers: New ASU study shows why we choose to follow others

‘Celtic curse’ genetic disease hotspots revealed in UK and Ireland

Study reveals two huge hot blobs of rock influence Earth’s magnetic field

RCT demonstrates effectiveness of mylovia, a digital therapy for female sexual dysfunction

Wistar scientists demonstrate first-ever single-shot HIV vaccine neutralization success

Medical AI models need more context to prepare for the clinic

Psilocybin shows context-dependent effects on social behavior and inflammation in female mice modeling anorexia

Mental health crisis: Global surveys expose who falls through the cracks and how to catch them

New boron compounds pave the way for easier drug development

Are cats ‘vegan’ meat eaters? Study finds why isotopic fingerprint of cat fur could trick us into thinking that way

Unexpected partial recovery of natural vision observed after intracortical microstimulation in a blind patient

From sea to soil: Molecular changes suggest how algae evolved into plants

Landmark study to explore whether noise levels in nurseries affect babies’ language development

Everyday diabetes medicine could treat common cause of blindness

Ultra-thin metasurface chip turns invisible infrared light into steerable visible beams

Cluster radioactivity in extreme laser fields: A theoretical exploration

Study finds banning energy disconnections shouldn’t destabilise markets

Researchers identify novel RNA linked to cancer patient survival

Poverty intervention program in Bangladesh may reinforce gender gaps, study shows

Novel approach to a key biofuel production step captures an elusive energy source

‘Ghost’ providers hinder access to health care for Medicaid patients

Study suggests far fewer cervical cancer screenings are needed for HPV‑vaccinated women

NUS CDE researchers develop new AI approach that keeps long-term climate simulations stable and accurate

UM School of Medicine launches clinical trial of investigative nasal spray medicine to prevent illnesses from respiratory viruses

Research spotlight: Use of glucose-lowering SGLT2i drugs may help patients with gout and diabetes take fewer medications

Genetic system makes worker cells more resilient producers of nanostructures for advanced sensing, therapeutics

[Press-News.org] Why aren’t more older adults getting flu or COVID-19 shots?
Poll suggests need for more communication about vaccines’ power to reduce risk of severe illness in people over 50